Anellotech Receives Additional Equity Investment from Multinational Strategic Investor and Corporate Partner in the BTX Supply Chain

March 17, 2016
Additional capital to fund the development of Anellotech’s Bio-TCat process to produce cost-competitive renewable aromatic chemicals.

Pearl River, New York – March 17, 2016 – Anellotech, a sustainable technology company focused on producing cost-competitive renewable chemicals from non-food biomass, today announced that the Company has received an additional $3 million equity investment from an unnamed and confidential multinational strategic investor and corporate partner. As previously announced on November 18, 2015, Anellotech received the first $7 million tranche of this now total $10 million investment from this investor.

The capital will be used to fund the development of Anellotech’s Bio-TCat process to produce cost-competitive renewable aromatic chemicals from non-food biomass, including the installation of Anellotech’s new, fully-integrated development and testing facility (“TCat-8™”), which broke ground earlier this year and will be operational in 2016.

“This equity investment further confirms the confidence already expressed by global leaders in process development, catalysis, engineering design, licensing and brand ownership have in the Bio-TCat process, and the opportunity for its broad application across a range of large, addressable global markets,” said David Sudolsky, President and CEO of Anellotech. “We will deploy this capital to confirm the viability and suitability of our process for scale-up, and generate the data needed to design commercial plants using Bio-TCat technology.”

Anellotech previously announced that its developmental R&D unit, TCat-8, which will be used extensively for this purpose, is now being installed at South Hampton Resources’ Silsbee, Texas facility.

About Anellotech
Anellotech is developing the Bio-TCat process to produce cost-competitive renewable aromatic chemicals (benzene, toluene and xylenes, “BTX”) from non-food biomass. Anellotech's key differentiator and ultimate competitive advantage is its use of a one-reactor catalytic process. Bio-TCat’s reactor outlet hydrocarbon product is substantially free of oxygen, and requires only mild hydrotreating to remove trace impurities, as often done in refineries. Contrast this with others’ multi-step pyrolysis processes that make a highly-oxygenated bio-oil intermediate product, which demand substantial amounts of costly hydrogen. Also, by using renewable and readily available non-food materials, such as wood, corn stover and bagasse, the Bio-TCat process is less expensive compared to processes relying on sugar as a feedstock, and avoids competition with the food chain. As a result, these renewable-sourced chemicals are expected to be produced and sold profitably against identical, petroleum-derived BTX counterparts. Anellotech complements its world-class R&D team with in-depth, highly-interactive, and long-term partnerships with leaders in process development, catalysis, engineering design, and licensing to accelerate development and drive cost-competitiveness. IFPEN is our process development and scale-up partner, Johnson Matthey is our catalyst development partner, and Axens is our partner for industrialization, commercialization, global licensing and technical support. Industry-leading strategic partners in the BTX supply chain, including Suntory and another multinational corporate investor that invested $10 million, have provided capital to Anellotech. For additional information, please visit:

For further information contact:

David Sudolsky Anellotech Inc. +1 (845) 735 7700

Cory Ziskind ICR, Inc. (646) 277 1232

Share This: